Namibia to pay less for TB medicine
J&J won’t enforce patent
South Africa is one of the biggest markets for Bedaquiline and the neighbouring country's health department has significant bargaining power to negotiate prices with campaigners.
Namibia is set to benefit from an agreement reached between South Africa's Competition Commission and pharmaceutical giant Johnson & Johnson (J&J), alongside its subsidiary Janssen
...
If you are an active subscriber and the article is not showing, please log out and back in. Free access to articles from 12:00.
Comments
Namibian Sun
No comments have been left on this article